Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Nitric oxide is involved in the cardioprotection of neonatal rat hearts, but not in neonatal ischemic postconditioning

J. Doul, M. Minaříková, Z. Charvátová, H. Maxová

. 2024 ; 12 (15) : e16147. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24019446

Grantová podpora
LX22NPO5104 National Institute for Research of Metabolic and Cardiovascular Diseases
20-02-00052 Ministry of Health of the Czech Republic

The cardioprotective effect of ischemic preconditioning (IPC) and ischemic postconditioning (IPoC) in adult hearts is mediated by nitric oxide (NO). During the early developmental period, rat hearts exhibit higher resistance to ischemia-reperfusion (I/R) injury, contain higher levels of serum nitrates, and their resistance cannot be further increased by IPC or IPoC. NOS blocker (L-NAME) lowers their high resistance. Wistar rat hearts (postnatal Days 1 and 10) were perfused according to Langendorff and exposed to 40 min of global ischemia followed by reperfusion with or without IPoC. NO and reactive oxygen species donors (DEA-NONO, SIN-1) and L-NAME were administered. Tolerance to ischemia decreased between Days 1 and 10. DEA-NONO (low concentrations) significantly increased tolerance to I/R injury on both Days 1 and 10. SIN-1 increased tolerance to I/R injury on Day 10, but not on Day 1. L-NAME significantly reduced resistance to I/R injury on Day 1, but actually increased resistance to I/R injury on Day 10. Cardioprotection by IPoC on Day 10 was not affected by either NO donors or L-NAME. It can be concluded that resistance of the neonatal heart to I/R injury is NO dependent, but unlike in adult hearts, cardioprotective interventions, such as IPoC, are most likely NO independent.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24019446
003      
CZ-PrNML
005      
20241024110731.0
007      
ta
008      
241015s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.14814/phy2.16147 $2 doi
035    __
$a (PubMed)39097984
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Doul, Jan $u Department of Pathophysiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000309012270
245    10
$a Nitric oxide is involved in the cardioprotection of neonatal rat hearts, but not in neonatal ischemic postconditioning / $c J. Doul, M. Minaříková, Z. Charvátová, H. Maxová
520    9_
$a The cardioprotective effect of ischemic preconditioning (IPC) and ischemic postconditioning (IPoC) in adult hearts is mediated by nitric oxide (NO). During the early developmental period, rat hearts exhibit higher resistance to ischemia-reperfusion (I/R) injury, contain higher levels of serum nitrates, and their resistance cannot be further increased by IPC or IPoC. NOS blocker (L-NAME) lowers their high resistance. Wistar rat hearts (postnatal Days 1 and 10) were perfused according to Langendorff and exposed to 40 min of global ischemia followed by reperfusion with or without IPoC. NO and reactive oxygen species donors (DEA-NONO, SIN-1) and L-NAME were administered. Tolerance to ischemia decreased between Days 1 and 10. DEA-NONO (low concentrations) significantly increased tolerance to I/R injury on both Days 1 and 10. SIN-1 increased tolerance to I/R injury on Day 10, but not on Day 1. L-NAME significantly reduced resistance to I/R injury on Day 1, but actually increased resistance to I/R injury on Day 10. Cardioprotection by IPoC on Day 10 was not affected by either NO donors or L-NAME. It can be concluded that resistance of the neonatal heart to I/R injury is NO dependent, but unlike in adult hearts, cardioprotective interventions, such as IPoC, are most likely NO independent.
650    _2
$a zvířata $7 D000818
650    12
$a oxid dusnatý $x metabolismus $7 D009569
650    12
$a potkani Wistar $7 D017208
650    12
$a ischemický postconditioning $x metody $7 D057775
650    12
$a novorozená zvířata $7 D000831
650    12
$a reperfuzní poškození myokardu $x prevence a kontrola $x metabolismus $7 D015428
650    _2
$a krysa rodu Rattus $7 D051381
650    12
$a NG-nitroargininmethylester $x farmakologie $7 D019331
650    _2
$a ischemické přivykání $x metody $7 D019157
650    _2
$a donory oxidu dusnatého $x farmakologie $7 D020030
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a srdce $x účinky léků $7 D006321
650    _2
$a myokard $x metabolismus $7 D009206
650    _2
$a molsidomin $x farmakologie $x analogy a deriváty $7 D008981
655    _2
$a časopisecké články $7 D016428
700    1_
$a Minaříková, Marcela $u Department of Physiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000234439885
700    1_
$a Charvátová, Zuzana $u Department of Pathophysiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0009000648063379
700    1_
$a Maxová, Hana $u Department of Pathophysiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $1 https://orcid.org/0000000314375615
773    0_
$w MED00198782 $t Physiological reports $x 2051-817X $g Roč. 12, č. 15 (2024), s. e16147
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39097984 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024110725 $b ABA008
999    __
$a ok $b bmc $g 2201969 $s 1231419
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 12 $c 15 $d e16147 $e - $i 2051-817X $m Physiological reports $n Physiol Rep $x MED00198782
GRA    __
$a LX22NPO5104 $p National Institute for Research of Metabolic and Cardiovascular Diseases
GRA    __
$a 20-02-00052 $p Ministry of Health of the Czech Republic
LZP    __
$a Pubmed-20241015

Najít záznam

Citační ukazatele

Možnosti archivace